Kyle Gordley, MD
Plastic and Reconstructive Surgery · Shenandoah, TXNPI 1437328002
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $493 and has fallen 51.0% since, to $242 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in TX, where the typical reported total is $2,813.
Across 44 payments — averaging $33.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$354
- AbbVie$317
- Mentor Worldwide LLC$128
- TELA Bio, Inc.$124
- Sientra, Inc.$101
- Smith+Nephew$67
- plus $387 from 12 others
What the payments were for
- Food & beverage$1,477100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 4 | $354 |
| AbbVie(2 entities) | 12 | $317 |
| Mentor Worldwide LLC | 5 | $128 |
| TELA Bio, Inc. | 5 | $124 |
| Sientra, Inc. | 2 | $101 |
| Smith+Nephew | 2 | $67 |
| Stryker | 3 | $57 |
| Medtronic | 1 | $49 |
| Axogen | 1 | $47 |
| Baxter Healthcare | 1 | $40 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $30 |
| Merz North America, Inc. | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Tepha Inc | 1 | $24 |
| RTI Surgical, Inc | 1 | $24 |
| Davol Inc. | 1 | $22 |
| Acell, Inc. | 1 | $20 |
How this compares
$1,477 in reported general payments places this provider in the 30th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $150 |
| Cephalexin | 33 | $119 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Shenandoah
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
- Ashley SteinbergBellaire$102K
- Eric MinnsLubbock$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.